Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older

NCT02544698 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Pneumococcal 13-valent Conjugate Vaccine

Interventions

BIOLOGICAL: One dose of PCV13a vaccine
BIOLOGICAL: One dose of PCV13a vaccine
BIOLOGICAL: three doses of PCV13a vaccine
BIOLOGICAL: three doses of PCV13a vaccine

Sponsor

Beijing Chaoyang District Centre for Disease Control and Prevention